Fundraising FoxOui Therapeutics
New Haven, US · 3 known investors
Find your way into Oui Therapeutics
Sign up to see every warm intro you have to Oui Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oui Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oui Therapeutics develops prescription digital therapeutics aimed at suicide prevention, including what it describes as the first digital therapeutic for suicide, currently in clinical trials. The company works with digital therapy and suicide experts to address suicidal behavior.
Investors · 3
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2023 | $766.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $375.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $659.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2021 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $399K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $481K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Oui Therapeutics do?
- Oui Therapeutics develops prescription digital therapeutics aimed at suicide prevention, including what it describes as the first digital therapeutic for suicide, currently in clinical trials. The company works with digital therapy and suicide experts to address suicidal behavior.
- Who are Oui Therapeutics's investors?
- Oui Therapeutics's investors include CU Healthcare Innovation Fund, CVS Health Ventures, Flare Capital Partners.
- Where is Oui Therapeutics headquartered?
- Oui Therapeutics is headquartered in New Haven, US.